MIOCA IN THE NEWS
Please see our news in the archive to the right.
MIOCA announces Outreach and Event Coordinator position
December 22, 2018
MIOCA is looking for a compassionate candidate who wants to contribute his/her skills and experience to support MIOCA’s mission and objectives.
Please click here for the full job description and directions to apply.
Application deadline: January 20, 2019
Tie Michigan Teal
June 1, 2018
MIOCA is gearing up for its state-wide ribbon tying campaign this September during National Ovarian Cancer Awareness Month. The Tie Michigan Teal
campaign is an important effort to make the public aware of the signs and symptoms of ovarian cancer. Tie Michigan Teal
Coordinator, Marcia Gurche, states, "Educating Michigan communities is an important part of MIOCA's mission. Ovarian cancer is a disease with no early detection test. Therefore, it is imperative that the symptoms are commonly known to promote early medical intervention."
MIOCA will be tying teal ribbons in downtown areas of cities and towns throughout Michigan. MIOCA will provide all of the materials, however, coordinators are needed to oversee the effort in each city/town. Each coordinator will receive a Tie Michigan Teal
t-shirt as a token of our appreciation. If interested in tying teal ribbons in a work place or on personal property, MIOCA will send a few cut ribbons to do that. Since not every city is a prime location for “tealing,” creativity and imagination are key for getting awareness out by using the ribbons.
Please contact Marcia Gurche at firstname.lastname@example.org for more information about Tie Michigan Teal
or to request materials.
2018 Geri Fournier Ovarian Cancer Research Award Recipients
April 4, 2018
It is with great pride and excitement that MIOCA announces the 2018 Geri Fournier Ovarian Cancer Research Award Recipients. Due to the tremendous support of MIOCA, the Board of Directors has once again increased the funds dedicated to ovarian cancer research here in Michigan. A total of $150,000 will fund three talented researchers working to improve treatment outcomes. MIOCA thanks all researchers who submitted proposals for consideration and congratulates the following $50,000 award recipients.
John Risinger, Ph.D.
Professor & Director of Gynecologic Oncology Research
Department of Obstetrics, Gynecology, & Reproductive Biology
Michigan State University College of Human Medicine
Mitochondrial disfunction in ARID1A mutant ovarian clear cell cancer
Professor, Ob/Gyn and Reproductive Biology
Michigan State University
Study of the Molecular Mechanisms Involved in High Grade Serous Progression from Metaplasia
Ira Winer, M.D., Ph.D.
Division of Gynecologic Oncology
Department of Oncology
Wayne State University/Karmanos Cancer Center
The Endoplasmic Reticulum, Cellular Stress and the unfolded Protein Response (UPR) in Ovarian Cancer Therapeutic Targeting
OCRFA Advocacy Day on Capitol Hill for FY2019 funding
March 6, 2018
MIOCA was well represented on Capitol Hill on March 6th by sending two MIOCA board members and eight survivors from Michigan to combine with 65 other advocates from across the country for the 2018
OCRFA Advocacy Day.
The Ovarian Cancer Research Fund Alliance organized the event in an effort to bring awareness of ovarian cancer to members of Congress and stress the need for continued funding for ovarian cancer research on the federal level. Our Michigan advocates had the opportunity to participate in meetings held in nine different House and Senate offices. Our voices were heard as we expressed the need for improving care for ovarian cancer patients, for increasing ovarian cancer funding through the congressionally directed medical research program, as well as continuing support of Johanna’s Law which provides for the critical education of the public.
If you could not attend Advocacy Day, you can still help in the effort by contacting Senator Stabenow or Senator Peters or your US Representative and urging them to fund/support the following ovarian cancer programs:
- +2.2 billion increase to NIH budget along with a proportional increase of at least $319 million for NCI
- $8 million Ovarian Cancer Control Initiative (OCCI)
- $5.5 for Johanna’s Law at CDC
- $30 million in funding for the ovarian cancer research program at the Department of Defense (a $10 million increase over 2018.)
- Oral Parity HR1409 – Has been introduced in the House but not in the Senate. Goal is advancing legislation in the House and to help generate interest in the Senate. Need our legislators to support this initiative.
- Encourage your representative to join the Ovarian Cancer Congressional Caucus if he/she has not already done so.